Innovation management business sector aims to create comprehensive platform to assist innovative life science & technology SMEs growing in China, and help Chinese local government create innovation ecosystem to improve healthcare. Partnered with Robert Bosch GmbH, SinoPharm Group and Medical Valley of Germany, Beijing YG is operating two iCCAMT centers in the most innovative areas of eastern China in Shanghai and Nanjing. Allied with CCUD of NDRC, Beijing YG is starting to create a flagship project, EU-China Healthcare Industry Cluster, in Shenzhen to facilitate life science & technology collaboration between China and European Commission.
The growing China market opens up new opportunities for innovative medical devices and healthcare services. The goal of YG Capital is to facilitate a seamless process for global medical technology companies to access the Chinese market. For clients who have already marketed their products or healthcare services outside China markets, we provide:
Regulatory support in China, e.g. product registration from CFDA
Reliable and fast distribution networks
Marketing strategies for China’s healthcare market
Funding and investment
Access to renowned hospitals in China
Facilitation of building local manufacture capability
Office space and intellectual property management
Financial Advisory: Investment partnering, Investment model analysis, Strategic plan formulation, Joint Venture advisory, M&A, etc.
PE/VC Investment: Jointly set up PE/VC fund with strategic partners to invest innovative medical technology that meet the China market needs.